The pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.6 billion in 2025 to $2.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to improvements in catheter-based intervention techniques, rising diagnosis of congenital heart defects, expansion of pediatric cardiac care centers, advancements in interventional imaging, increased surgeon expertise in minimally invasive procedures.
The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expansion of next-generation pediatric cardiac devices, rising demand for less invasive treatment options, growing investments in pediatric cardiac infrastructure, integration of advanced imaging and navigation systems, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive cardiac procedures, rising use of transcatheter heart valves, growing demand for pediatric-specific cardiac devices, expansion of image-guided catheterization techniques, enhanced focus on early congenital defect intervention.
The increasing prevalence of congenital heart disease is expected to drive the growth of the pediatric interventional cardiology market. Congenital heart disease refers to structural or functional abnormalities of the heart present at birth. Pediatric interventional cardiology procedures, such as catheter-based interventions, offer advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and minimal scarring. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, heart defects are the most common birth defects in the United States, affecting approximately 1% of all births - around 40,000 infants annually. This rising prevalence underscores the growing need for minimally invasive cardiac procedures in pediatric populations, thereby propelling market growth.
Pedistric population drives the pediatric interventional cardiology market going forward. This demographic refers to individuals within specific age brackets typically associated with childhood and adolescence. According to the Federal Interagency Forum on Child and Family Statistics, the U.S. had around 72.5 million children in 2022, projected to reach 78.2 million by 2050. The rise in this population, spanning different age groups, is expected to fuel the demand for pediatric interventional cardiology procedures.
Major companies in the pediatric interventional cardiology market are prioritizing the development of technological innovations, such as three-dimensional transesophageal echocardiography (3D TEE), to secure a competitive advantage. In pediatric interventional cardiology, real-time 3D TEE provides intricate images of congenital heart defects, including atrial and ventricular septal defects, which are vital for planning and guiding minimally invasive procedures. For example, in January 2024, Philips, a healthcare technology company based in the Netherlands, launched the X11-4T Mini 3D TEE transducer. This state-of-the-art transducer enhances three-dimensional transesophageal echocardiography (TEE) by delivering detailed imaging essential for diagnosing congenital heart defects in children. Notable features include its compact design, which improves maneuverability in pediatric patients, high-resolution imaging capabilities that boost diagnostic accuracy, and compatibility with existing echocardiography systems for a seamless workflow. These advancements substantially enhance procedural outcomes and patient care within pediatric cardiology.
Major companies operating in the pediatric interventional cardiology market are Medtronic plc, Abbott Laboratories, Terumo Corporation, W. L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Biosensors International Group Ltd., Asahi Intecc Co Ltd, Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH.
North America was the largest region in the pediatric interventional cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric interventional cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pediatric interventional cardiology market by increasing costs of imported catheters, stents, valves, imaging components, and precision-manufactured cardiac devices. Hospitals and cardiac centers in North America and Europe are most affected due to reliance on imported specialized devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing procedural costs and impacting device procurement. However, they are also encouraging regional device manufacturing, local supplier development, and innovation in cost-optimized pediatric cardiac solutions.
The pediatric interventional cardiology market research report is one of a series of new reports that provides pediatric interventional cardiology market statistics, including pediatric interventional cardiology industry global market size, regional shares, competitors with a pediatric interventional cardiology market share, detailed pediatric interventional cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric interventional cardiology industry. This pediatric interventional cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric interventional cardiology involves utilizing cardiac catheterization in children to both diagnose and treat congenital heart defects through minimally invasive procedures. These procedures aim to address various heart conditions while minimizing surgical invasiveness.
Key devices within pediatric interventional cardiology encompass closure devices, trans catheter heart valves, atherectomy devices, catheters, balloons, stents, among others. Closure devices encompass a range of fittings that, when securely fastened in a closed position, mitigate or prevent air emissions by sealing openings in containers or their exteriors. The primary procedures in pediatric interventional cardiology involve catheter-based valve implantation, correction of congenital heart defects, angioplasty, coronary thrombectomy, and other methodologies. These procedures find application in clinical testing labs, hospitals, cardiac centers, pediatric clinics, and research institutions, contributing significantly to diagnosing and managing cardiac conditions in children.
The pediatric interventional cardiology market includes revenues earned by entities by percutaneous coronary intervention services, atrial septal defect services, cardiac catheterization services, and trans catheter aortic valve replacement services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pediatric interventional cardiology market also consists of sales of plaque modification devices, guide wire, vascular closure devices, and atherectomy device. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expansion of next-generation pediatric cardiac devices, rising demand for less invasive treatment options, growing investments in pediatric cardiac infrastructure, integration of advanced imaging and navigation systems, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive cardiac procedures, rising use of transcatheter heart valves, growing demand for pediatric-specific cardiac devices, expansion of image-guided catheterization techniques, enhanced focus on early congenital defect intervention.
The increasing prevalence of congenital heart disease is expected to drive the growth of the pediatric interventional cardiology market. Congenital heart disease refers to structural or functional abnormalities of the heart present at birth. Pediatric interventional cardiology procedures, such as catheter-based interventions, offer advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and minimal scarring. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, heart defects are the most common birth defects in the United States, affecting approximately 1% of all births - around 40,000 infants annually. This rising prevalence underscores the growing need for minimally invasive cardiac procedures in pediatric populations, thereby propelling market growth.
Pedistric population drives the pediatric interventional cardiology market going forward. This demographic refers to individuals within specific age brackets typically associated with childhood and adolescence. According to the Federal Interagency Forum on Child and Family Statistics, the U.S. had around 72.5 million children in 2022, projected to reach 78.2 million by 2050. The rise in this population, spanning different age groups, is expected to fuel the demand for pediatric interventional cardiology procedures.
Major companies in the pediatric interventional cardiology market are prioritizing the development of technological innovations, such as three-dimensional transesophageal echocardiography (3D TEE), to secure a competitive advantage. In pediatric interventional cardiology, real-time 3D TEE provides intricate images of congenital heart defects, including atrial and ventricular septal defects, which are vital for planning and guiding minimally invasive procedures. For example, in January 2024, Philips, a healthcare technology company based in the Netherlands, launched the X11-4T Mini 3D TEE transducer. This state-of-the-art transducer enhances three-dimensional transesophageal echocardiography (TEE) by delivering detailed imaging essential for diagnosing congenital heart defects in children. Notable features include its compact design, which improves maneuverability in pediatric patients, high-resolution imaging capabilities that boost diagnostic accuracy, and compatibility with existing echocardiography systems for a seamless workflow. These advancements substantially enhance procedural outcomes and patient care within pediatric cardiology.
Major companies operating in the pediatric interventional cardiology market are Medtronic plc, Abbott Laboratories, Terumo Corporation, W. L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Biosensors International Group Ltd., Asahi Intecc Co Ltd, Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH.
North America was the largest region in the pediatric interventional cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric interventional cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pediatric interventional cardiology market by increasing costs of imported catheters, stents, valves, imaging components, and precision-manufactured cardiac devices. Hospitals and cardiac centers in North America and Europe are most affected due to reliance on imported specialized devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing procedural costs and impacting device procurement. However, they are also encouraging regional device manufacturing, local supplier development, and innovation in cost-optimized pediatric cardiac solutions.
The pediatric interventional cardiology market research report is one of a series of new reports that provides pediatric interventional cardiology market statistics, including pediatric interventional cardiology industry global market size, regional shares, competitors with a pediatric interventional cardiology market share, detailed pediatric interventional cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric interventional cardiology industry. This pediatric interventional cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric interventional cardiology involves utilizing cardiac catheterization in children to both diagnose and treat congenital heart defects through minimally invasive procedures. These procedures aim to address various heart conditions while minimizing surgical invasiveness.
Key devices within pediatric interventional cardiology encompass closure devices, trans catheter heart valves, atherectomy devices, catheters, balloons, stents, among others. Closure devices encompass a range of fittings that, when securely fastened in a closed position, mitigate or prevent air emissions by sealing openings in containers or their exteriors. The primary procedures in pediatric interventional cardiology involve catheter-based valve implantation, correction of congenital heart defects, angioplasty, coronary thrombectomy, and other methodologies. These procedures find application in clinical testing labs, hospitals, cardiac centers, pediatric clinics, and research institutions, contributing significantly to diagnosing and managing cardiac conditions in children.
The pediatric interventional cardiology market includes revenues earned by entities by percutaneous coronary intervention services, atrial septal defect services, cardiac catheterization services, and trans catheter aortic valve replacement services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pediatric interventional cardiology market also consists of sales of plaque modification devices, guide wire, vascular closure devices, and atherectomy device. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pediatric Interventional Cardiology Market Characteristics
3. Pediatric Interventional Cardiology Market Supply Chain Analysis
4. Global Pediatric Interventional Cardiology Market Trends and Strategies
5. Pediatric Interventional Cardiology Market Analysis of End Use Industries
7. Global Pediatric Interventional Cardiology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pediatric Interventional Cardiology Total Addressable Market (TAM) Analysis for the Market
9. Pediatric Interventional Cardiology Market Segmentation
10. Pediatric Interventional Cardiology Market Regional and Country Analysis
11. Asia-Pacific Pediatric Interventional Cardiology Market
12. China Pediatric Interventional Cardiology Market
13. India Pediatric Interventional Cardiology Market
14. Japan Pediatric Interventional Cardiology Market
15. Australia Pediatric Interventional Cardiology Market
16. Indonesia Pediatric Interventional Cardiology Market
17. South Korea Pediatric Interventional Cardiology Market
18. Taiwan Pediatric Interventional Cardiology Market
19. South East Asia Pediatric Interventional Cardiology Market
20. Western Europe Pediatric Interventional Cardiology Market
21. UK Pediatric Interventional Cardiology Market
22. Germany Pediatric Interventional Cardiology Market
23. France Pediatric Interventional Cardiology Market
24. Italy Pediatric Interventional Cardiology Market
25. Spain Pediatric Interventional Cardiology Market
26. Eastern Europe Pediatric Interventional Cardiology Market
27. Russia Pediatric Interventional Cardiology Market
28. North America Pediatric Interventional Cardiology Market
29. USA Pediatric Interventional Cardiology Market
30. Canada Pediatric Interventional Cardiology Market
31. South America Pediatric Interventional Cardiology Market
32. Brazil Pediatric Interventional Cardiology Market
33. Middle East Pediatric Interventional Cardiology Market
34. Africa Pediatric Interventional Cardiology Market
36. Pediatric Interventional Cardiology Market Competitive Landscape and Company Profiles
37. Pediatric Interventional Cardiology Market Other Major and Innovative Companies
40. Pediatric Interventional Cardiology Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pediatric Interventional Cardiology Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pediatric interventional cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pediatric interventional cardiology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric interventional cardiology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Closure Devices; Catheters2) By Procedure: Congenital Heart Defect Closure Procedures; Balloon-Based Interventions; Transcatheter Pulmonary Valve Procedures; Ductal And Vascular Interventions; Hybrid And Other Pediatric Interventional Procedures
3) By End-Use: Hospitals; Cardiac Centers
Subsegments:
1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices; Ventricular Septal Defect (VSD) Closure Devices; Patent Ductus Arteriosus (PDA) Closure Devices2) By Catheters: Diagnostic Catheters; Therapeutic Catheters; Guiding Catheters
Companies Mentioned: Medtronic plc; Abbott Laboratories; Terumo Corporation; W. L. Gore & Associates Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Numed Inc.; St. Jude Medical Inc.; Cordis Corporation; Koninklijke Philips N.V.; Biotronik; B. Braun Melsungen AG; Johnson and Johnson; Cook Group LLC; Teleflex Incorporated; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Lepu Medical Technology Beijing Co Ltd; Biosensors International Group Ltd.; Asahi Intecc Co Ltd; Medinol Ltd.; Jotec GmbH; Hexacath Ltd.; Translumina GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pediatric Interventional Cardiology market report include:- Medtronic plc
- Abbott Laboratories
- Terumo Corporation
- W. L. Gore & Associates Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Numed Inc.
- St. Jude Medical Inc.
- Cordis Corporation
- Koninklijke Philips N.V.
- Biotronik
- B. Braun Melsungen AG
- Johnson and Johnson
- Cook Group LLC
- Teleflex Incorporated
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- Lepu Medical Technology Beijing Co Ltd
- Biosensors International Group Ltd.
- Asahi Intecc Co Ltd
- Medinol Ltd.
- Jotec GmbH
- Hexacath Ltd.
- Translumina GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.81 Billion |
| Forecasted Market Value ( USD | $ 3.92 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
